Quantcast
US Market Closed
Oct 15,2018
NIKKEI 225  22271.3
-423.36 ▼-1.87%
OMXN40  1449.11
-1.4 ▼-0.1%
FTSE100  6859.15
-34.77 ▼-0.5%

Stock Market Overview

Index Value Change Net / %
Data as of Oct 15, 2018
 


Stock Market News & Analysis


Stock Activity

Company Last Sale* Change Net / % Share Volume
$26.26 0.08 ▼ 0.30% 68,667,779
$172.21 2.11 ▼ 1.21% 59,592,011
$13.75 0.51 ▲ 3.85% 38,067,428
$107.60 1.97 ▼ 1.80% 29,705,879
$217.36 4.75 ▼ 2.14% 27,731,630
As of 10/15/2018 4:00:00 PM

Company Last Sale* Change Net / % Share Volume
$7.80 1.59 ▲ 25.61% 9,988
$11.74 1.88 ▲ 19.07% 24,472,277
$14.22 1.66 ▲ 13.22% 255,127
$165.64 17.34 ▲ 11.69% 5,782,078
$2.63 0.23 ▲ 9.58% 215,146
As of 10/15/2018 4:00:00 PM

Company Last Sale* Change Net / % Share Volume
$2.77 0.81 ▼ 22.63% 1,597,081
$13.01 1.88 ▼ 12.63% 189,692
$2.92 0.36 ▼ 10.98% 1,452,391
$33.095 4.01 ▼ 10.80% 4,715,377
$10.69 1.24 ▼ 10.39% 2,576,334
As of 10/15/2018 4:00:00 PM

Company Last Sale* Change Net / % Share Volume
$1,760.95 27.66 ▼ 1.55% 6,375,583
$172.21 2.11 ▼ 1.21% 64,650,417
$217.36 4.75 ▼ 2.14% 30,362,512
$333.13 6.43 ▼ 1.89% 11,187,114
$107.60 1.97 ▼ 1.80% 31,997,514
As of 10/15/2018 4:00:00 PM

Company Last Sale Price Change Net / % Share Volume Volume % Change
$14.40 2.33 ▲ 19.30% 3,351,961 2589%
$15.88 2.58 ▲ 19.40% 4,511,725 1004%
$220.91 25.13 ▲ 12.84% 3,988,832 627%
$173.25 18.38 ▲ 11.87% 4,663,136 604%
$38.39 2.90 ▲ 8.17% 1,007,281 416%
As of 10/15/2018 4:10:00 PM

Upcoming IPOs

Name Price Range
ETON PHARMACEUTICALS, $6.00
ALZHEON, INC. $13.00 - $15.00
LOGICBIO THERAPEUTICS, $12.00 - $14.00

Earnings

Earnings Calendar

Visit Earnings Calendar for the week starting 10/14; 189 reports are scheduled.

Company Last Sale* Change Net / %
BAC$27.920.54 ▼ 1.9%

Recommendations

Forecasts

Surprises


ETFs

Decliners

Advancers


Today at Nasdaq







Market Musings

Martin Tillier's daily read on the markets.

Martin Tillier

The Week in ETFs

A weekly briefing on major news, trends and players shaping the world of ETFs.



Investing Ideas

Richard Saintvilus offers actionable investing insights.

x